Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

A $500 annual blood testing membership promises to help consumers take their health into their own hands. Can it deliver?

I first heard about Function Health the way a lot of us probably did, through a wave of social media buzz and wellness ...

This biotech startup develops innovative urine-based tests for early cancer diagnosis, revolutionizing healthcare with advanced diagnostic solutions.

Chemicals produced as the body converts ultra-processed food and drink into energy can be found in people’s blood and urine, researchers reported May 20 in the journal PLOS Medicine.

Researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of prostate cancer as an alternative to a PSA test, aiding early diagnosis.

Self-screenings for HPV are now being offered at Sonora Quest Laboratories in Arizona, the medical company announced on Tuesday.

A urine test for prostate cancer has shown signs of being far more accurate than the blood screening currently used to track the disease.

A simple, painless urine test could detect prostate cancer early with high precision, even more accurate than the current blood test, and can be performed at home without being invasive.

Do you have a chance of getting kidney stones or parathyroid disease? A calcium urine test can help your doctor diagnose the problem.

A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of a prospective multicenter study.The approach — which outperformed ...